Related Experiment Video
Updated: Jan 29, 2026

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
Published on: December 29, 2023
Sub-Inhibitory Concentrations of Metronidazole Enhance Production, Virulence Factor Loading, and Endothelial
Zixiang Wu1, Xia Li1, Song Ge1
1School of Stomatology, Zunyi Medical University, Zunyi 563000, China.
Abstract:
Porphyromonas gingivalis (P. gingivalis), a key periodontal pathogen, has been linked to atherosclerosis development. The clinical failure of antibiotics to improve cardiovascular outcomes necessitates alternative explanations. This study examines how sub-inhibitory concentrations of metronidazole affect the biogenesis and pathogenic potential of P. gingivalis extracellular vesicles (EVs) on human umbilical vein endothelial cells (HUVECs). EVs were isolated from both untreated bacteria (N-EVs) and those treated with sub-inhibitory concentrations of metronidazole (M-EVs) through ultracentrifugation. Characterization included transmission electron microscopy (TEM), nanoparticle tracking analysis, and Western blotting for virulence factors. HUVECs were evaluated using viability, migration, cell death assays, ROS detection, NF-κB activation imaging, and cytokine measurement. Sub-inhibitory concentrations of metronidazole increased EV production by 2.3-fold and enriched M-EVs with virulence factors (lipid A LPS, Kgp, RgpA). M-EVs demonstrated significantly stronger cytotoxicity, causing greater impairment of HUVEC viability and migration, alongside increased cell death. Mechanistically, M-EVs induced elevated mitochondrial and cellular ROS, promoting NF-κB activation and enhancing secretion of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6). Sub-inhibitory concentrations of metronidazole exacerbate endothelial injury by amplifying EV production and virulence factor loading in P. gingivalis, offering a mechanistic explanation for the limited cardiovascular benefits of antibiotic therapy in periodontitis patients.
Insights
Sub-inhibitory metronidazole boosts virulence factor-laden extracellular vesicles from Porphyromonas gingivalis, worsening endothelial cell injury. This explains why antibiotics may not fully prevent cardiovascular issues in periodontitis.
Area of Science:
- Microbiology
- Cardiovascular Research
- Cell Biology
Background:
- Porphyromonas gingivalis is a key periodontal pathogen linked to atherosclerosis.
- Antibiotic treatment failures in cardiovascular outcomes necessitate exploring alternative mechanisms.
Purpose of the Study:
- To investigate the impact of sub-inhibitory metronidazole on P. gingivalis extracellular vesicle (EV) production and pathogenicity.
- To assess the effects of metronidazole-altered EVs on human umbilical vein endothelial cells (HUVECs).
Main Methods:
- EVs were isolated from P. gingivalis cultures with and without sub-inhibitory metronidazole.
- EVs were characterized using TEM, NTA, and Western blotting.
- HUVEC responses were evaluated through viability, migration, cell death, ROS, NF-κB, and cytokine assays.
Main Results:
- Sub-inhibitory metronidazole increased EV production by 2.3-fold and enriched EVs with virulence factors.
- Metronidazole-treated EVs (M-EVs) exhibited enhanced cytotoxicity, impairing HUVEC viability and migration.
- M-EVs induced higher ROS levels, promoted NF-κB activation, and increased pro-inflammatory cytokine secretion.
Conclusions:
- Sub-inhibitory metronidazole amplifies P. gingivalis EV production and virulence factor loading.
- This exacerbates endothelial injury, providing a mechanism for limited cardiovascular benefits of antibiotics in periodontitis.
- Findings highlight the complex interplay between P. gingivalis, EVs, and cardiovascular disease progression.
Related Concept Videos
Cable Subjected to Concentrated Loads
Concentration Cells
Consider the following voltaic cell:
Transcription Factors
Factors Affecting Solubility
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Solution Concentration and Dilution

